Your browser doesn't support javascript.
loading
Research progress on molecular mechanism of transcription factor C/EBPβ in lung diseases / 中华危重病急救医学
Chinese Critical Care Medicine ; (12): 875-880, 2022.
Article em Zh | WPRIM | ID: wpr-956069
Biblioteca responsável: WPRO
ABSTRACT
CCAAT enhancer binding protein β (C/EBPβ), as a nuclear transcription factor necessary for the development of liver, airway epithelium, and adipose tissue, plays a vital role in physiological processes related to cell proliferation, apoptosis, and differentiation. However, the up-regulation of C/EBPβ activates signal pathways related to inflammatory response, epithelial-mesenchymal transition, cell proliferation and invasion, immune response, and angiogenesis by regulating a series of downstream genes transcription promotes the development of lung diseases. Therefore, targeting C/EBPβ may be a potential treatment strategy for lung diseases. This paper summarizes the regulatory effects of C/EBPβ and related signaling pathways in lung infection, asthma, chronic obstructive pulmonary disease, lung injury, pulmonary fibrosis, and lung cancer to provide a theoretical basis for the precision medicine of lung diseases.
Palavras-chave
Texto completo: 1 Base de dados: WPRIM Idioma: Zh Revista: Chinese Critical Care Medicine Ano de publicação: 2022 Tipo de documento: Article
Texto completo: 1 Base de dados: WPRIM Idioma: Zh Revista: Chinese Critical Care Medicine Ano de publicação: 2022 Tipo de documento: Article